Institutions / Spruce Street Capital LP
Spruce Street Capital LP
CIK 2050194 · Institution · as of Dec 31, 2025
Portfolio value
$302.66M
Positions
27
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 27 →
| Company | Value | % of portfolio |
|---|---|---|
| Cidara Therapeutics Inc | $51.31M | 17.0% |
| Relay Therapeutics, Inc. | $25.25M | 8.3% |
| Lb Pharmaceuticals IncLBRX | $22.38M | 7.4% |
| Relmada Therapeutics, Inc. | $19.74M | 6.5% |
| Vaxcyte, Inc. | $18.47M | 6.1% |
| Kiniksa Pharmaceuticals International, plc | $17.94M | 5.9% |
| EyePoint, Inc. | $17.93M | 5.9% |
| Savara IncSVRA | $14.54M | 4.8% |
| Erasca, Inc.ERAS | $14.47M | 4.8% |
| Dianthus Therapeutics, Inc. | $12.26M | 4.0% |
| Surrozen, Inc./DESRZN | $9.76M | 3.2% |
| Ocular Therapeutix, Inc | $9.52M | 3.1% |
| SAB Biotherapeutics, Inc. | $8.22M | 2.7% |
| Inhibikase Therapeutics, Inc. | $7.34M | 2.4% |
| Enliven Therapeutics, Inc.ELVN | $6.87M | 2.3% |
| Minerva Neurosciences, Inc. | $6.66M | 2.2% |
| Abivax SA | $6.62M | 2.2% |
| Cybin Inc. | $6.30M | 2.1% |
| KalVista Pharmaceuticals Inc | $6.27M | 2.1% |
| Enanta Pharmaceuticals Inc | $6.15M | 2.0% |
| Alto Neuroscience, Inc.ANRO | $3.97M | 1.3% |
| LeonaBio, Inc.LONA | $2.98M | 1.0% |
| Centessa Pharmaceuticals PLC | $1.95M | 0.6% |
| Alector, Inc. | $1.74M | 0.6% |
| Lexeo Therapeutics, Inc. | $1.74M | 0.6% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.